Scientists have discovered what could be a breakthrough in the treatment of Alzheimer’s disease. Over 7 million Americans are living with Alzheimer’s, which slowly erodes memory, cognitive skills and ...

Shares of Nexalin Technology nearly doubled after the company said its second-generation Sync neurostimulation device can improve cognitive performance and enhance brain network connectivity in ...

Stranger Things 5 doesn’t premiere until Wednesday, November 26 (a.k.a. Thanksgiving Eve; note the premiere time of 8 p.m. ET ...

A Washington man appeared to be destined to develop Alzheimer’s disease — but against all genetic odds, he has eluded the common dementia for decades. Researchers at the Washington University School ...

FDA cleared the Elecsys pTau181 test as the first blood-based biomarker to aid in the initial assessment of Alzheimer's disease and other causes of cognitive decline that can be used in the primary ...

ST. PAUL, Minn., Oct. 6 (UPI) --Spanish and Chinese scientists said Monday they have used specifically tailored nanoparticles to clear out build-ups of a key toxin linked to Alzheimer's disease in the ...

Scientists are searching for the secret in Doug Whitney’s biology that has protected him from dementia, hoping it could lead to ways to treat or prevent Alzheimer’s for many other people. Doug Whitney ...

Instead of targeting neurons, the researchers specifically sought to repair a critical part of the brain that keeps disease-inducing toxins out. Reading time: Reading time 2 minutes Scientists on ...

Scientists have achieved a “striking” reversal of Alzheimer’s disease in mice by restoring the normal function of the brain's vasculature—the network of blood vessels that supplies it with oxygen and ...

Oct 13 (Reuters) - Roche Diagnostics (ROG.S), opens new tab said on Monday the U.S. Food and Drug Administration cleared its and partner Eli Lilly's (LLY.N), opens new tab blood test as an aid in the ...

The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...

Low doses in mice have can clear up proteins associated with Alzheimer’s disease and restore memory. Human trials are the next step. Lithium has long been a standard treatment in bipolar disorder, but ...